Glycosylated hemoglobin levels are associated with cardiovascular events in nondiabetic peritoneal dialysis patients

Journal of Nephrology

Volumn 25, Issue 1, 2012, Pages 107-112

  Dheir, Hamad ^a   Ozkahya, Mehmet ^a   Kircelli, Fatih ^a   Demirci, Meltem Sezis ^a   Asci, Gulay ^a   Toz, Huseyin ^a   Ertilav, Muhittin ^a   Kose, Timur ^a   Ok, Ercan ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Cardiovascular events; Glycosylated hemoglobin; Hemoglobin A1c; Peritoneal dialysis

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; EVENT FREE SURVIVAL; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SUDDEN DEATH; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; UNSTABLE ANGINA PECTORIS; BLOOD; CHRONIC KIDNEY FAILURE; DISEASE FREE SURVIVAL; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DISEASE-FREE SURVIVAL; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; YOUNG ADULT;

EID: 84862263980     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/JN.2011.8350     Document Type: Article

References (21)

1. US Renal Data System. USRDS 1999 annual data report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1999.
2. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type II diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-234.
3. Longenecker JC, Coresh J, Powe NR, et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: The CHOI ̇CE Study. J Am Soc Nephrol. 2002;13:1918-1927.
4. Laakso M. Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus: The Finnish studies. Ann Intern Med. 1996;124(1 Pt 2):127-130.
5. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782-787.
6. Gerstein HC. Glucose: a continuous risk factor for cardiovascular disease. Diabet Med. 1997;14(Suppl 3):S25-S31.
7. Balkau B, Shipley M, Jarrett R, et al. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care. 1998;21:360-367.
8. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med. 2004;141:413-420.
9. Park S, Barrett-Connor E, Wingard DL, Shan J, Edelstein S. GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study. Diabetes Care. 1996;19:450-456.
10. Singer DE, Nathan DM, Anderson KM, Wilson PW, Evans JC. Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes. 1992;41:202-208.
11. Blake GJ, Pradhan AD, Manson JE, et al. Hemoglobin A1c level and future cardiovascular events among women. Arch Intern Med. 2004;164:757-761.
12. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362:800-811.
13. Menon V, Greene T, Pereira AA, et al. Glycolated hemoglobin and mortality in patients with non-diabetic chronic kidney disease. J Am Soc Nephrol. 2005;16:3411-3417.
14. Davies SJ, Phillips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol. 2001; 12:1046-1051.
15. Kalantar-Zadeh K, Kopple JD, Regidor DL, et al. HbA1c and survival in maintenance hemodialysis patients. Diabetes Care. 2007;30:1049-1055.
16. Twardowski ZJ. Clinical value of standardized equilibration tests in CAPD patients. Blood Purif. 1989;7:95-108.
17. Farias MA, McClellan W, Soucie JM, Mitch WE. A prospective comparison of methods for determining if cardiovascular disease is a predictor of mortality in dialysis patients. Am J Kidney Dis. 1994;23:382-388.
18. Selvin E, Coresh J, Golden SH, Brancati FL, Folsom AR, Steffes MW. Glycemic control and coronary heart disease risk in persons with and without diabetes. The Atherosclerosis Risk in Communities Study. Arch Intern Med. 2005;165:1910-1916.
19. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care. 1999;22:233-240.
20. Chen J, Gu D, Chen CS, et al. Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrol Dial Transplant. 2007;22:1100-1106.
21. Sarnak MJ, Coronado BE, Greene T, et al. Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol. 2002;57:327-335.